Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Final ban for human dura mater products in France:

This article was originally published in Clinica

Executive Summary

The French government has published a final ban on the import, export and use of human dura mater products and has ordered the withdrawal of all products containing the tissue. The French health directorate issued the final of three bans following reports by the French national research body, INSERM about possible dangers from transfer of Creutzfeldt-Jakob disease and statements from medical consulting organisations that human dura mater is not irreplaceable in surgery. Costs involved in withdrawing products must be met by the manufacturer or importer.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089571

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel